Low incidence of acute GVHD and relapse in standard risk patients undergoing allogeneic transplantation with CSA and MTX prophylaxis

被引：0
|
作者：
Byrne, JL [1 ]
Stainer, C [1 ]
Miflin, G [1 ]
Haynes, AP [1 ]
Russell, NH [1 ]
机构：
[1] City Hosp Nottingham, Nottingham, England
来源：
BONE MARROW TRANSPLANTATION | 1998年 / 21卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
409
引用
收藏
页码：S118 / S118
页数：1
相关论文
共 50 条
  • [31] Grouping of Genetic Risk By the European Leukemia Net Classification Predicts Overall Survival and Relapse Incidence in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation
    Hemmati, Philipp G.
    Terwey, Theis
    Na, Il-Kang
    Jehn, Christian
    Vuong, Lam G.
    Le Coutre, Philipp
    Doerken, Bernd
    Arnold, Renate
    BLOOD, 2015, 126 (23)
  • [32] Efficacy of low-dose zoster prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation
    Kristen Mascarenhas
    Jennifer Berano Teh
    Kelly Peng
    Heeyoung Kim
    Andrew Sy
    Stephen J. Forman
    F. Lennie Wong
    Ryotaro Nakamura
    Sanjeet S. Dadwal
    Saro H. Armenian
    Bone Marrow Transplantation, 2020, 55 : 1662 - 1664
  • [33] Allogeneic transplantation of Bcr-Abl positive acute lymphoblastic leukaemia is associated with a low incidence of relapse
    Weisser, M
    Tischer, J
    Ledderose, G
    Kolb, HJ
    BONE MARROW TRANSPLANTATION, 2004, 33 : S237 - S237
  • [34] Acute GVHD prophylaxis with standard-dose, micro-dose or no MTX after fludarabine/melphalan conditioning
    Chen, G. L.
    Zhang, Y.
    Hahn, T.
    Abrams, S.
    Ross, M.
    Liu, H.
    McCarthy, P. L.
    BONE MARROW TRANSPLANTATION, 2014, 49 (02) : 248 - 253
  • [35] Efficacy of low-dose zoster prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation
    Mascarenhas, Kristen
    Teh, Jennifer Berano
    Peng, Kelly
    Kim, Heeyoung
    Sy, Andrew
    Forman, Stephen J.
    Wong, F. Lennie
    Nakamura, Ryotaro
    Dadwal, Sanjeet S.
    Armenian, Saro H.
    BONE MARROW TRANSPLANTATION, 2020, 55 (08) : 1662 - 1664
  • [36] Older recipient age is paradoxically associated with a lower incidence of chronic GVHD in Thymoglobulin recipients: a retrospective study exploring risk factors for GVHD in allogeneic transplantation with Thymoglobulin GVHD prophylaxis
    A B M Lim
    J Storek
    A Beligaswatte
    M Collins
    M Tacey
    T Williamson
    K Mason
    E Li
    M A Chaudhry
    J A Russell
    A Daly
    J Szer
    I Lewis
    D Ritchie
    Bone Marrow Transplantation, 2015, 50 : 566 - 572
  • [37] Incidence and Risk Factors for Central Nervous System Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Leukemia
    Dhir, Aditi
    Hanna, Rabi
    Rybicki, Lisa
    Abounader, Donna
    Flagg, Aron
    Hamilton, Betty Ky
    Hill, Brian
    Jagadeesh, Deepa
    Liu, Hein
    Gerds, Aaron
    Kalaycio, Matt E.
    Bolwel, Brian
    Majhail, Navneet S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S201 - S202
  • [38] Older recipient age is paradoxically associated with a lower incidence of chronic GVHD in Thymoglobulin recipients: a retrospective study exploring risk factors for GVHD in allogeneic transplantation with Thymoglobulin GVHD prophylaxis
    Lim, A. B. M.
    Storek, J.
    Beligaswatte, A.
    Collins, M.
    Tacey, M.
    Williamson, T.
    Mason, K.
    Li, E.
    Chaudhry, M. A.
    Russell, J. A.
    Daly, A.
    Szer, J.
    Lewis, I.
    Ritchie, D.
    BONE MARROW TRANSPLANTATION, 2015, 50 (04) : 566 - 572
  • [39] Acute GVHD prophylaxis with standard-dose, micro-dose or no MTX after fludarabine/melphalan conditioning
    G L Chen
    Y Zhang
    T Hahn
    S Abrams
    M Ross
    H Liu
    P L McCarthy
    Bone Marrow Transplantation, 2014, 49 : 248 - 253
  • [40] The Relationship of Acute Gvhd and Pre- and Post-Transplant Flow-MRD to the Incidence and Timing of Relapse in Children Undergoing Allogeneic Transplantation for High Risk ALL: Defining a Target Population and Window for Immunological Intervention to Prevent Relapse
    Pulsipher, Michael A.
    Langholz, Bryan
    Wall, Donna A.
    Schultz, Kirk R.
    Bunin, Nancy
    Gastier-Foster, Julie M.
    Borowitz, Michael J.
    Goyal, Rakesh
    Gardner, Sharon
    Carroll, William L.
    Raetz, Elizabeth
    Grupp, Stephan A.
    BLOOD, 2012, 120 (21)
12345